PPD treatment for anal and genital warts in people with HIV
Part of Immune system & allergy, Infections, Skin clinical trials.
This trial tests if a tuberculosis skin test substance (PPD) injected into anogenital warts can help clear them in people with HIV. It aims to find a new treatment option that boosts your immune system locally.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have anal or genital warts confirmed by a doctor.
- You need to be living with HIV (your HIV status will be checked).
- You cannot have a history of tuberculosis or a positive TB test.
- You cannot have had severe allergic reactions to PPD or have active skin conditions like generalized dermatitis or asthma.
- You cannot be taking drugs that suppress your immune system (like steroids) or other immune-modulating medicines.
- You cannot have other sexually transmitted infections (like syphilis or hepatitis B) at the time of screening.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug called ACU-D1 for people with HIV who have high-grade abnormal cell growth (HSIL) on their vulva or perianal area. The goal is to see if the drug can help treat these HPV-related lesions.
This study tests a new injection-based treatment for common warts (the bumpy growths on skin caused by a virus). Researchers want to see if this approach works better than current options and is safe for patients.
This trial tests whether an experimental vaccine (ID93 + GLA-SE) can improve outcomes in people being treated for drug-sensitive tuberculosis. It is for those newly diagnosed or who have been on standard TB treatment for a few months.
This study tests different ways to screen for HPV (a virus linked to cervical cancer) in women living with HIV. The goal is to find the best, most practical screening approach to catch cervical problems early.
This study tests a new DNA vaccine (ICVAX) designed to help your immune system better control HIV. You'll receive injections over several months if your HIV is well-controlled with current medications.
This study looks at how well the HPV vaccine works in women living with HIV and whether it helps make cervical cancer screening more accurate. If you are a woman with HIV between 21 and 40 years old and already part of certain other HIV studies, you may be able to join.
Hear when a new Anogenital Warts trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.